Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

Background: Immune checkpoint inhibitors (ICIs) have significantly changed the current approach to cancer treatment. Although the use of ICIs has become the standard of care for advanced melanoma, reports of ICI use among Asian populations with melanoma are limited. Therefore, we conducted this retr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Wu, Chiao-En, Yang, Chan-Keng, Peng, Meng-Ting, Huang, Pei-Wei, Lin, Yu-Fen, Cheng, Chi-Yuan, Chang, Yao-Yu, Chen, Huan-Wu, Hsieh, Jia-Juan, Chang, John Wen-Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7287159/
https://ncbi.nlm.nih.gov/pubmed/32582554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00905
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados